Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
- View all (279)
- Volume 9, 2022 (32)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 279 records -
Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study
Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W
Journal of Hepatocellular Carcinoma 2022, 9:437-451
Published Date: 20 May 2022
Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
Zhang G
Journal of Hepatocellular Carcinoma 2022, 9:423-436
Published Date: 19 May 2022
RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma
Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L
Journal of Hepatocellular Carcinoma 2022, 9:405-422
Published Date: 9 May 2022
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y
Journal of Hepatocellular Carcinoma 2022, 9:389-403
Published Date: 9 May 2022
Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P
Journal of Hepatocellular Carcinoma 2022, 9:379-387
Published Date: 5 May 2022

Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells

Zhang C, Xie Y, Lai R, Wu J, Guo Z
Journal of Hepatocellular Carcinoma 2022, 9:367-377
Published Date: 3 May 2022
Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
Kim K, Lee J, Seong J
Journal of Hepatocellular Carcinoma 2022, 9:357-366
Published Date: 29 April 2022
An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
Guo Y, Ren Y, Dong X, Kan X, Zheng C
Journal of Hepatocellular Carcinoma 2022, 9:343-355
Published Date: 26 April 2022
Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression

Yu CL, Lee HL, Yang SF, Wang SW, Lin CP, Hsieh YH, Chiou HL
Journal of Hepatocellular Carcinoma 2022, 9:327-341
Published Date: 24 April 2022
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M
Journal of Hepatocellular Carcinoma 2022, 9:315-325
Published Date: 19 April 2022
Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B
Hsueh RC, Wu WJ, Lin CL, Liu CJ, Huang YW, Hu JT, Wu CF, Sung FY, Liu WJ, Yu MW
Journal of Hepatocellular Carcinoma 2022, 9:301-313
Published Date: 11 April 2022
MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene
Niu Z, Yang F, Li H, Wang J, Ni Q, Ma C, Zhu H, Chang H, Zhou X, Lu J, Gao H
Journal of Hepatocellular Carcinoma 2022, 9:289-300
Published Date: 8 April 2022
Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma
Dai Y, Jiang H, Feng ST, Xia Y, Li J, Zhao S, Wang D, Zeng X, Chen Y, Xin Y, Liu D
Journal of Hepatocellular Carcinoma 2022, 9:273-288
Published Date: 5 April 2022
Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma
Zhang JX, Chen P, Liu S, Zu QQ, Shi HB, Zhou CG
Journal of Hepatocellular Carcinoma 2022, 9:265-272
Published Date: 31 March 2022
Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook
Fan Y, Xue H, Zheng H
Journal of Hepatocellular Carcinoma 2022, 9:233-263
Published Date: 30 March 2022
Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer
Ren P, Wang K, Ma J, Cao X, Zhao J, Zhao C, Guo Y, Ye H
Journal of Hepatocellular Carcinoma 2022, 9:221-232
Published Date: 29 March 2022
LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment
Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y
Journal of Hepatocellular Carcinoma 2022, 9:203-220
Published Date: 22 March 2022
Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma
Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, He Y, Zhang H, Chen D, Chen H, Liao W
Journal of Hepatocellular Carcinoma 2022, 9:189-201
Published Date: 20 March 2022
Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma
Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X
Journal of Hepatocellular Carcinoma 2022, 9:171-188
Published Date: 11 March 2022
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K
Journal of Hepatocellular Carcinoma 2022, 9:157-170
Published Date: 10 March 2022
The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, Li Y, Huang Q, Jiang Y, Chen S, Lv L, Li D, Zeng JZ
Journal of Hepatocellular Carcinoma 2022, 9:141-155
Published Date: 8 March 2022
Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study
Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y
Journal of Hepatocellular Carcinoma 2022, 9:127-140
Published Date: 8 March 2022
MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met
Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X
Journal of Hepatocellular Carcinoma 2022, 9:113-126
Published Date: 27 February 2022
Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma
Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y
Journal of Hepatocellular Carcinoma 2022, 9:99-112
Published Date: 18 February 2022
SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
Ma X, Zhuang H, Wang Q, Yang L, Xie Z, Zhang Z, Tan W, Tang C, Chen Y, Shang C
Journal of Hepatocellular Carcinoma 2022, 9:83-98
Published Date: 15 February 2022
Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach
Thomas J, Liao LM, Sinha R, Patel T, Antwi SO
Journal of Hepatocellular Carcinoma 2022, 9:69-81
Published Date: 15 February 2022
CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Zhang X, Wang X, Jia L, Yang Y, Yang F, Xiao S
Journal of Hepatocellular Carcinoma 2022, 9:57-67
Published Date: 11 February 2022
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y
Journal of Hepatocellular Carcinoma 2022, 9:41-56
Published Date: 9 February 2022
Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival
Young S, Ragulojan R, Chen T, Owen J, D'souza D, Sanghvi T, Golzarian J, Flanagan S
Journal of Hepatocellular Carcinoma 2022, 9:29-39
Published Date: 4 February 2022
Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction]
Ouyang T, Liu J, Shi C, Zhu L, Guo X
Journal of Hepatocellular Carcinoma 2022, 9:27-28
Published Date: 28 January 2022
Surgical Strategy for Resecting Hepatocellular Carcinoma in the Caudate Lobe: Isolated or Combined Lobectomy? A Single-Center Study and Meta-Analysis

Xu ZG, Zhang FH, Sun DW, Zheng QT, Ji GW, Wang K
Journal of Hepatocellular Carcinoma 2022, 9:13-25
Published Date: 26 January 2022
Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program
Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang KY, Nadir A
Journal of Hepatocellular Carcinoma 2022, 9:1-11
Published Date: 22 January 2022
Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway
Wang C, Lv Y, Sha Z, Zhang J, Wu J, Qi Y, Guo Z
Journal of Hepatocellular Carcinoma 2021, 8:1643-1653
Published Date: 29 December 2021
Acyl-CoA Thioesterase 7 is Transcriptionally Activated by Krüppel-Like Factor 13 and Promotes the Progression of Hepatocellular Carcinoma
Xie X, Chen C, Feng S, Zuo S, Zhao X, Li H
Journal of Hepatocellular Carcinoma 2021, 8:1623-1641
Published Date: 23 December 2021
Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
Deng Z, Huang K, Liu D, Luo N, Liu T, Han L, Du D, Lian D, Zhong Z, Peng J
Journal of Hepatocellular Carcinoma 2021, 8:1607-1622
Published Date: 18 December 2021
Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018
Shankaran V, Chennupati S, Sanchez H, Sun Q, Li L, Fedorenko C, Aly A, Healey M, Seal B
Journal of Hepatocellular Carcinoma 2021, 8:1597-1606
Published Date: 14 December 2021
Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S
Journal of Hepatocellular Carcinoma 2021, 8:1579-1596
Published Date: 8 December 2021
Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study
Kim MA, Jang H, Choi NR, Nam JY, Lee YB, Cho EJ, Lee JH, Yu SJ, Kim HC, Chung JW, Yoon JH, Kim YJ
Journal of Hepatocellular Carcinoma 2021, 8:1565-1577
Published Date: 7 December 2021
Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver
Feng J, Zhu R, Yin Y, Wang S, Zhou L, Lv F, Zhao D
Journal of Hepatocellular Carcinoma 2021, 8:1537-1563
Published Date: 7 December 2021
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B
Journal of Hepatocellular Carcinoma 2021, 8:1525-1535
Published Date: 3 December 2021
Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
Young S, Cam I, Gencturk M, Rubin N, D'souza D, Flanagan S, Golzarian J, Sanghvi T
Journal of Hepatocellular Carcinoma 2021, 8:1513-1524
Published Date: 1 December 2021
PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, Ren Z, Dong Z, Yu Z
Journal of Hepatocellular Carcinoma 2021, 8:1495-1511
Published Date: 1 December 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M
Journal of Hepatocellular Carcinoma 2021, 8:1485-1493
Published Date: 30 November 2021
Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography
Dong Z, Lin Y, Lin F, Luo X, Lin Z, Zhang Y, Li L, Li ZP, Feng ST, Cai H, Peng Z
Journal of Hepatocellular Carcinoma 2021, 8:1473-1484
Published Date: 30 November 2021
Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
Ouyang T, Liu J, Shi C, Zhu L, Guo X
Journal of Hepatocellular Carcinoma 2021, 8:1459-1471
Published Date: 26 November 2021
Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma
Huang J, Huang W, Zhan M, Guo Y, Liang L, Cai M, Lin L, He M, Lian H, Lu L, Zhu K
Journal of Hepatocellular Carcinoma 2021, 8:1445-1458
Published Date: 26 November 2021
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G
Journal of Hepatocellular Carcinoma 2021, 8:1415-1444
Published Date: 25 November 2021
Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
De Battista D, Zamboni F, Gerstein H, Sato S, Markowitz TE, Lack J, Engle RE, Farci P
Journal of Hepatocellular Carcinoma 2021, 8:1399-1413
Published Date: 21 November 2021
Role of Rab GTPases in Hepatocellular Carcinoma
Yang CC, Meng GX, Dong ZR, Li T
Journal of Hepatocellular Carcinoma 2021, 8:1389-1397
Published Date: 19 November 2021
An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study
Li FY, Li JG, Wu SS, Ye HL, He XQ, Zeng QJ, Zheng RQ, An C, Li K
Journal of Hepatocellular Carcinoma 2021, 8:1375-1388
Published Date: 15 November 2021
Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K, Li N, Lv Y, Liu Z
Journal of Hepatocellular Carcinoma 2021, 8:1367-1373
Published Date: 13 November 2021
Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma
Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C
Journal of Hepatocellular Carcinoma 2021, 8:1355-1365
Published Date: 12 November 2021
CircANTXR1 Contributes to the Malignant Progression of Hepatocellular Carcinoma by Promoting Proliferation and Metastasis
Huang C, Yu W, Wang Q, Huang T, Ding Y
Journal of Hepatocellular Carcinoma 2021, 8:1339-1353
Published Date: 9 November 2021
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis
Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T
Journal of Hepatocellular Carcinoma 2021, 8:1323-1338
Published Date: 3 November 2021
Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study
Li HZ, Tan J, Tang T, An TZ, Li JX, Xiao YD
Journal of Hepatocellular Carcinoma 2021, 8:1311-1322
Published Date: 1 November 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
Hsiang CW, Huang WY, Yang JF, Shen PC, Dai YH, Wang YF, Lin CS, Chang WC, Lo CH
Journal of Hepatocellular Carcinoma 2021, 8:1299-1309
Published Date: 29 October 2021
Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]
Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH
Journal of Hepatocellular Carcinoma 2021, 8:1297-1298
Published Date: 27 October 2021
Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels
Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z
Journal of Hepatocellular Carcinoma 2021, 8:1281-1295
Published Date: 27 October 2021
Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features
Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg AS, Mayer P, Pfeiffenberger J, Hoffmann K
Journal of Hepatocellular Carcinoma 2021, 8:1269-1279
Published Date: 22 October 2021
Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
Wang X, Liu X, Wang P, Yu L, Yan F, Yan H, Zhou D, Yang Z
Journal of Hepatocellular Carcinoma 2021, 8:1253-1267
Published Date: 21 October 2021
Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring
Che YQ, Zhang Y, Li HB, Shen D, Cui W
Journal of Hepatocellular Carcinoma 2021, 8:1241-1252
Published Date: 12 October 2021
Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Wu JY, Yin ZY, Bai YN, Chen YF, Zhou SQ, Wang SJ, Zhou JY, Li YN, Qiu FN, Li B, Yan ML
Journal of Hepatocellular Carcinoma 2021, 8:1233-1240
Published Date: 5 October 2021
Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial
Wang LZ, Hu XX, Shen XC, Wang TC, Zhou S
Journal of Hepatocellular Carcinoma 2021, 8:1221-1232
Published Date: 5 October 2021
An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma
Kronenfeld JP, Goel N
Journal of Hepatocellular Carcinoma 2021, 8:1209-1219
Published Date: 28 September 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
Gok Yavuz B, Hasanov E, Lee SS, Mohamed YI, Curran MA, Koay EJ, Cristini V, Kaseb AO
Journal of Hepatocellular Carcinoma 2021, 8:1195-1207
Published Date: 24 September 2021
Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
Huber TC, Bochnakova T, Koethe Y, Park B, Farsad K
Journal of Hepatocellular Carcinoma 2021, 8:1181-1193
Published Date: 23 September 2021
Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma
Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S
Journal of Hepatocellular Carcinoma 2021, 8:1169-1179
Published Date: 24 September 2021
Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study
Gandhi M, Ling WH, Chen CH, Lee JH, Kudo M, Chanwat R, Strasser SI, Xu Z, Lai SH, Chow PKH
Journal of Hepatocellular Carcinoma 2021, 8:1159-1167
Published Date: 23 September 2021
Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction
Pathak S, Sonbol MB
Journal of Hepatocellular Carcinoma 2021, 8:1147-1158
Published Date: 21 September 2021
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
Kaseb AO, Kappadath SC, Lee SS, Raghav KP, Mohamed YI, Xiao L, Morris JS, Ohaji C, Avritscher R, Odisio BC, Kuban J, Abdelsalam ME, Chasen B, Elsayes KM, Elbanan M, Wolff RA, Yao JC, Mahvash A
Journal of Hepatocellular Carcinoma 2021, 8:1129-1145
Published Date: 9 September 2021
Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review
Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X
Journal of Hepatocellular Carcinoma 2021, 8:1117-1127
Published Date: 7 September 2021
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
Khan AR, Wei X, Xu X
Journal of Hepatocellular Carcinoma 2021, 8:1089-1115
Published Date: 7 September 2021
An Overview of the Genomic Characterization of Hepatocellular Carcinoma
Yim SY, Lee JS
Journal of Hepatocellular Carcinoma 2021, 8:1077-1088
Published Date: 7 September 2021

Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma
Fu S, Pan M, Zhang J, Zhang H, Tang Z, Li Y, Mu W, Huang J, Dong D, Duan C, Li X, Wang S, Chen X, He X, Yan J, Lu L, Tian J
Journal of Hepatocellular Carcinoma 2021, 8:1065-1076
Published Date: 4 September 2021
A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
Mai H, Xie H, Hou J, Chen H, Zhou B, Hou J, Jiang D
Journal of Hepatocellular Carcinoma 2021, 8:1055-1064
Published Date: 2 September 2021
Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances
Charneau J, Suzuki T, Shimomura M, Fujinami N, Nakatsura T
Journal of Hepatocellular Carcinoma 2021, 8:1035-1054
Published Date: 2 September 2021
Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Chen HZ, Shen AG, Wang GR
Journal of Hepatocellular Carcinoma 2021, 8:1023-1034
Published Date: 31 August 2021
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma

Dai T, Ye L, Yu H, Li K, Li J, Liu R, Lu X, Deng M, Li R, Liu W, Yang Y, Wang G
Journal of Hepatocellular Carcinoma 2021, 8:997-1021
Published Date: 30 August 2021
Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
Liao H, Shi J, Wen K, Lin J, Liu Q, Shi B, Yan Y, Xiao Z
Journal of Hepatocellular Carcinoma 2021, 8:985-996
Published Date: 24 August 2021
MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
Zhou C, Ni X, Lu X, Wang Y, Qian X, Yang C, Zeng M
Journal of Hepatocellular Carcinoma 2021, 8:975-983
Published Date: 21 August 2021
Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
Liu CM, Huang BS, Yen YH, Wang YM, Huang EY, Hsu HC, Huang TT, Yang YH, Cheng JY
Journal of Hepatocellular Carcinoma 2021, 8:963-973
Published Date: 18 August 2021
Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese
Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J, Xiao Q, Ren W, Zhou B, Hou J, Jiang D
Journal of Hepatocellular Carcinoma 2021, 8:951-961
Published Date: 16 August 2021

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
Chang WC, Hsu HH, Chiu SH, Huang WY, Lo CH, Lin HH, Huang PC, Shih YL, Wan YL
Journal of Hepatocellular Carcinoma 2021, 8:937-949
Published Date: 14 August 2021
Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
Kilany S, Ata L, Gomaa A, Sabry A, Nada A, Tharwa ES, Badra G, Abogabal A, Elwaraky M, Moaz E, Ezzat S, Elsharawy A, Waked I
Journal of Hepatocellular Carcinoma 2021, 8:925-935
Published Date: 12 August 2021

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection

Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH
Journal of Hepatocellular Carcinoma 2021, 8:913-923
Published Date: 10 August 2021
SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
Ma Z, Li Z, Wang S, Zhou Q, Ma Z, Liu C, Huang B, Zheng Z, Yang L, Zou Y, Zhang C, Huang S, Hou B
Journal of Hepatocellular Carcinoma 2021, 8:899-912
Published Date: 7 August 2021
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
D'Alessio A, Rimassa L, Cortellini A, Pinato DJ
Journal of Hepatocellular Carcinoma 2021, 8:887-897
Published Date: 5 August 2021
DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma
Guo Y, Luo W, Huang S, Zhao W, Chen H, Ma Y, Ye M, Nie Y, Zhang Y, Huang C, Zhou Q, He X, Chen M
Journal of Hepatocellular Carcinoma 2021, 8:871-885
Published Date: 3 August 2021

Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated
De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB
Journal of Hepatocellular Carcinoma 2021, 8:861-870
Published Date: 30 July 2021
Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Nevarez NM, Yopp AC
Journal of Hepatocellular Carcinoma 2021, 8:851-860
Published Date: 28 July 2021
Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J
Journal of Hepatocellular Carcinoma 2021, 8:837-850
Published Date: 28 July 2021
DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines
Sun Y, Tang X, Ye B, Ding K
Journal of Hepatocellular Carcinoma 2021, 8:823-836
Published Date: 27 July 2021

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL
Journal of Hepatocellular Carcinoma 2021, 8:809-822
Published Date: 24 July 2021

Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
Chen Y, Chen J, Zhang Y, Lin Z, Wang M, Huang L, Huang M, Tang M, Zhou X, Peng Z, Huang B, Feng ST
Journal of Hepatocellular Carcinoma 2021, 8:795-808
Published Date: 22 July 2021
Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study
Chen Y, Zhao J, Zhang Z, Ding Z, Chen Y, Chen X, Zhang W
Journal of Hepatocellular Carcinoma 2021, 8:783-794
Published Date: 21 July 2021
Prediction of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization: A Real-World Study Based on Non-Contrast Computed Tomography Radiomics and General Image Features
Guo Z, Zhong N, Xu X, Zhang Y, Luo X, Zhu H, Zhang X, Wu D, Qiu Y, Tu F
Journal of Hepatocellular Carcinoma 2021, 8:773-782
Published Date: 9 July 2021
SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
Song Y, Li Z, Li L, Zhou H, Zeng TT, Jin C, Lin JR, Gao S, Li Y, Guan XY, Zhu YH
Journal of Hepatocellular Carcinoma 2021, 8:759-771
Published Date: 6 July 2021

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Fornari F, Giovannini C, Piscaglia F, Gramantieri L
Journal of Hepatocellular Carcinoma 2021, 8:741-757
Published Date: 2 July 2021
Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
D'Ambrosio R, Degasperi E, Lampertico P
Journal of Hepatocellular Carcinoma 2021, 8:713-739
Published Date: 29 June 2021
Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
Ismail MS, Mohamed I, Polychronopoulou E, Goss JA, Kuo YF, Kanwal F, Jalal PK
Journal of Hepatocellular Carcinoma 2021, 8:701-711
Published Date: 29 June 2021
Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells
Wang MJ, Chen JJ, Song SH, Su J, Zhao LH, Liu QG, Yang T, Chen Z, Liu C, Fu ZR, Hu YP, Chen F
Journal of Hepatocellular Carcinoma 2021, 8:685-699
Published Date: 29 June 2021

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
Sheng R, Huang J, Zhang W, Jin K, Yang L, Chong H, Fan J, Zhou J, Wu D, Zeng M
Journal of Hepatocellular Carcinoma 2021, 8:671-683
Published Date: 29 June 2021
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang AP, Zhang YY, Fu YZ, Chen JB, Wang JC, Wang X, Zhang YJ, Hu DD, Chen MS
Journal of Hepatocellular Carcinoma 2021, 8:657-670
Published Date: 25 June 2021
An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice

Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK
Journal of Hepatocellular Carcinoma 2021, 8:645-656
Published Date: 24 June 2021
Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria
Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J
Journal of Hepatocellular Carcinoma 2021, 8:625-644
Published Date: 21 June 2021
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
Cho YY, Yu SJ, Lee HW, Kim DY, Kang W, Paik YH, Sung PS, Bae SH, Park SC, Doh YS, Kim KM, Jang ES, Kim IH, Kim W, Kim YJ
Journal of Hepatocellular Carcinoma 2021, 8:613-623
Published Date: 18 June 2021
Blocking the CCL5–CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells
Zhuang Y, Zhao X, Yuan B, Zeng ZC, Chen Y
Journal of Hepatocellular Carcinoma 2021, 8:599-611
Published Date: 18 June 2021
Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Chung SW, Park MK, Cho YY, Park Y, Lee CH, Oh H, Jang H, Kim MA, Kim SW, Nam JY, Lee YB, Cho EJ, Yu SJ, Kim HC, Kim YJ, Chung JW, Yoon JH, Lee JH
Journal of Hepatocellular Carcinoma 2021, 8:587-598
Published Date: 15 June 2021
Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
Mathew AS, Dawson LA
Journal of Hepatocellular Carcinoma 2021, 8:575-586
Published Date: 14 June 2021
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
Karbeyaz F, Kissling S, Jaklin PJ, Bachofner J, Brunner B, Müllhaupt B, Winder T, Mertens JC, Misselwitz B, von Felten S, Siebenhüner AR
Journal of Hepatocellular Carcinoma 2021, 8:565-574
Published Date: 11 June 2021
Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
Chong H, Gong Y, Pan X, Liu A, Chen L, Yang C, Zeng M
Journal of Hepatocellular Carcinoma 2021, 8:545-563
Published Date: 9 June 2021
The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
Zhou Z, Lin L, An Y, Zhan M, Chen Y, Cai M, Zhu X, Lu L, Zhu K
Journal of Hepatocellular Carcinoma 2021, 8:529-543
Published Date: 8 June 2021
Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB
Journal of Hepatocellular Carcinoma 2021, 8:513-527
Published Date: 31 May 2021
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma
Monge C, Xie C, Steinberg SM, Greten TF
Journal of Hepatocellular Carcinoma 2021, 8:507-512
Published Date: 31 May 2021
Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications
Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY
Journal of Hepatocellular Carcinoma 2021, 8:493-505
Published Date: 28 May 2021
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
Granito A, Marinelli S, Forgione A, Renzulli M, Benevento F, Piscaglia F, Tovoli F
Journal of Hepatocellular Carcinoma 2021, 8:477-492
Published Date: 26 May 2021
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK
Journal of Hepatocellular Carcinoma 2021, 8:467-476
Published Date: 25 May 2021
The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target
Guan X, Lu Y, Zhu H, Yu S, Zhao W, Chi X, Xie C, Yin Z
Journal of Hepatocellular Carcinoma 2021, 8:451-465
Published Date: 20 May 2021

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Jiang Y, Han Q, Zhao H, Zhang J
Journal of Hepatocellular Carcinoma 2021, 8:435-450
Published Date: 20 May 2021

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma


Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK
Journal of Hepatocellular Carcinoma 2021, 8:421-434
Published Date: 17 May 2021

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide
Müller L, Stoehr F, Mähringer-Kunz A, Hahn F, Weinmann A, Kloeckner R
Journal of Hepatocellular Carcinoma 2021, 8:403-419
Published Date: 13 May 2021

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M
Journal of Hepatocellular Carcinoma 2021, 8:387-401
Published Date: 13 May 2021

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
Gramantieri L, Giovannini C, Piscaglia F, Fornari F
Journal of Hepatocellular Carcinoma 2021, 8:369-385
Published Date: 12 May 2021
Clinical, Pathological and Genetic Characteristics of Pediatric Hepatocellular Carcinoma Associated with Hepatitis B Virus Infection
Zhao P, Lu Y, Wang C, Wang L, Li J, Li M
Journal of Hepatocellular Carcinoma 2021, 8:361-367
Published Date: 10 May 2021
Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma
Fan Y, Yu Y, Wang X, Hu M, Du M, Guo L, Sun S, Hu C
Journal of Hepatocellular Carcinoma 2021, 8:349-359
Published Date: 5 May 2021
LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940
Zhang Y, Zhang H, Wu S
Journal of Hepatocellular Carcinoma 2021, 8:333-348
Published Date: 3 May 2021
Current Status of Therapeutic Choice and Feasibility for Patients with Hepatocellular Carcinoma Aged ≥ 70 Years: A Nationwide Cancer Registry Analysis
Rho SY, Lee HW, Kim DY, Kim KS
Journal of Hepatocellular Carcinoma 2021, 8:321-332
Published Date: 30 April 2021
Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation
Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M, Elkassar H
Journal of Hepatocellular Carcinoma 2021, 8:313-320
Published Date: 29 April 2021
Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
Zhong Y, Yang Y, He L, Zhou Y, Cheng N, Chen G, Zhao B, Wang Y, Wang G, Liu X
Journal of Hepatocellular Carcinoma 2021, 8:301-312
Published Date: 29 April 2021
Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
Ye F, Huang W, Xue Y, Tang E, Wang M, Shi F, Wei D, Han Y, Chen P, Zhang X, Yu D
Journal of Hepatocellular Carcinoma 2021, 8:285-300
Published Date: 27 April 2021
ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
Liu G, Li J, Zhang CY, Huang DY, Xu JW
Journal of Hepatocellular Carcinoma 2021, 8:271-284
Published Date: 21 April 2021
Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors
Chen L, Liu ZX, Bi QC, Zhao J, Liang QR, Tang Q
Journal of Hepatocellular Carcinoma 2021, 8:263-270
Published Date: 20 April 2021
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
Zhang YF, Shi M, Lu LH, Wang L, Guo RP
Journal of Hepatocellular Carcinoma 2021, 8:253-261
Published Date: 19 April 2021

A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician’s Choice in a New Therapeutic Scenario
Dipasquale A, Marinello A, Santoro A
Journal of Hepatocellular Carcinoma 2021, 8:241-251
Published Date: 15 April 2021

NAFLD-Associated HCC: Progress and Opportunities
Geh D, Anstee QM, Reeves HL
Journal of Hepatocellular Carcinoma 2021, 8:223-239
Published Date: 8 April 2021
High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
Guo X, Tian S, Cao P, Xie Y, Dong W
Journal of Hepatocellular Carcinoma 2021, 8:211-222
Published Date: 6 April 2021

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N
Journal of Hepatocellular Carcinoma 2021, 8:193-209
Published Date: 29 March 2021
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L
Journal of Hepatocellular Carcinoma 2021, 8:177-191
Published Date: 29 March 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP
Journal of Hepatocellular Carcinoma 2021, 8:167-176
Published Date: 25 March 2021
Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country
Galun D, Bogdanovic A, Zivanovic M, Zuvela M
Journal of Hepatocellular Carcinoma 2021, 8:155-165
Published Date: 23 March 2021
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
Park R, Lopes da Silva L, Nissaisorakarn V, Riano I, Williamson S, Sun W, Saeed A
Journal of Hepatocellular Carcinoma 2021, 8:145-154
Published Date: 22 March 2021
Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections
Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M
Journal of Hepatocellular Carcinoma 2021, 8:133-143
Published Date: 18 March 2021
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S
Journal of Hepatocellular Carcinoma 2021, 8:119-132
Published Date: 16 March 2021

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
Liang L, Wang MD, Zhang YM, Zhang WG, Zhang CW, Lau WY, Shen F, Pawlik TM, Huang DS, Yang T
Journal of Hepatocellular Carcinoma 2021, 8:103-118
Published Date: 12 March 2021
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN
Journal of Hepatocellular Carcinoma 2021, 8:85-101
Published Date: 12 March 2021
Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model
Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF
Journal of Hepatocellular Carcinoma 2021, 8:71-83
Published Date: 9 March 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ
Journal of Hepatocellular Carcinoma 2021, 8:57-69
Published Date: 3 March 2021
Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Shi T, Kobara H, Oura K, Masaki T
Journal of Hepatocellular Carcinoma 2021, 8:45-55
Published Date: 11 February 2021
Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis
Kim K, Kim TH, Kim TH, Seong J
Journal of Hepatocellular Carcinoma 2021, 8:35-44
Published Date: 11 February 2021
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma
Li S, Xu W, Liao M, Zhou Y, Weng J, Ren L, Yu J, Liao W, Huang Z
Journal of Hepatocellular Carcinoma 2021, 8:23-33
Published Date: 9 February 2021
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
Liu Q, Dong X
Journal of Hepatocellular Carcinoma 2021, 8:19-21
Published Date: 28 January 2021
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
Ely A, Bloom K, Maepa MB, Arbuthnot P
Journal of Hepatocellular Carcinoma 2021, 8:1-17
Published Date: 27 January 2021
Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel
Zhou C, Shi Q, Liu J, Huang S, Yang C, Xiong B
Journal of Hepatocellular Carcinoma 2020, 7:447-456
Published Date: 31 December 2020
Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right Atrium
Lee HA, Rim CH
Journal of Hepatocellular Carcinoma 2020, 7:435-446
Published Date: 21 December 2020
Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR
Journal of Hepatocellular Carcinoma 2020, 7:423-433
Published Date: 21 December 2020
Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
Zong J, Fan Z, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:413-422
Published Date: 18 December 2020

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK
Journal of Hepatocellular Carcinoma 2020, 7:403-412
Published Date: 17 December 2020
Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant
Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB
Journal of Hepatocellular Carcinoma 2020, 7:385-401
Published Date: 17 December 2020
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M
Journal of Hepatocellular Carcinoma 2020, 7:377-384
Published Date: 16 December 2020
Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma
Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K
Journal of Hepatocellular Carcinoma 2020, 7:361-376
Published Date: 8 December 2020
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
Gao X, Zhan M, Wang L, Ding Y, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:347-360
Published Date: 1 December 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:337-345
Published Date: 1 December 2020
Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma
Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J
Journal of Hepatocellular Carcinoma 2020, 7:331-335
Published Date: 18 November 2020
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
Hu B, Yang XB, Sang XT
Journal of Hepatocellular Carcinoma 2020, 7:315-330
Published Date: 11 November 2020
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N
Journal of Hepatocellular Carcinoma 2020, 7:301-313
Published Date: 9 November 2020
Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y
Journal of Hepatocellular Carcinoma 2020, 7:289-299
Published Date: 2 November 2020
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:271-288
Published Date: 29 October 2020
miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation
Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G
Journal of Hepatocellular Carcinoma 2020, 7:257-269
Published Date: 29 October 2020
Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
Xu W, Liu F, Shen X, Li R
Journal of Hepatocellular Carcinoma 2020, 7:233-256
Published Date: 27 October 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:219-232
Published Date: 23 October 2020
Assessing the Survival Benefit of Surgery and Various Types of Radiation Therapy for Treatment of Hepatocellular Carcinoma: Evidence from the Surveillance, Epidemiology, and End Results Registries
Shi F, Wang C, Kong Y, Yang L, Li J, Zhu G, Guo J, Zheng Q, Zhang B, Wang S
Journal of Hepatocellular Carcinoma 2020, 7:201-218
Published Date: 19 October 2020
Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study
Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X
Journal of Hepatocellular Carcinoma 2020, 7:191-199
Published Date: 15 October 2020
Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I
Journal of Hepatocellular Carcinoma 2020, 7:181-189
Published Date: 14 October 2020
The Clinicopathological and Imaging Characteristics of Primary Hepatic Carcinosarcoma and a Review of the Literature
Bin F, Chen Z, Liu P, Liu J, Mao Z
Journal of Hepatocellular Carcinoma 2020, 7:169-180
Published Date: 13 October 2020
Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma
Wu B, Jia F, Li X, Zhang M, Han D, Jia Z
Journal of Hepatocellular Carcinoma 2020, 7:159-168
Published Date: 9 October 2020
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization
Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN
Journal of Hepatocellular Carcinoma 2020, 7:155-158
Published Date: 28 September 2020
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO
Journal of Hepatocellular Carcinoma 2020, 7:143-153
Published Date: 16 September 2020
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
Raybould AL, Sanoff H
Journal of Hepatocellular Carcinoma 2020, 7:133-142
Published Date: 15 September 2020
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC
Journal of Hepatocellular Carcinoma 2020, 7:117-131
Published Date: 14 September 2020
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
Campani C, Bensi C, Milani S, Galli A, Tarocchi M
Journal of Hepatocellular Carcinoma 2020, 7:107-116
Published Date: 30 July 2020
Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation
Ren A, Li Z, Zhang X, Deng R, Ma Y
Journal of Hepatocellular Carcinoma 2020, 7:101-106
Published Date: 7 July 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations
Debaillon Vesque A, Decraecker M, Blanc JF
Journal of Hepatocellular Carcinoma 2020, 7:91-99
Published Date: 9 June 2020

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM
Journal of Hepatocellular Carcinoma 2020, 7:77-89
Published Date: 23 April 2020

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
Dash S, Aydin Y, Widmer KE, Nayak L
Journal of Hepatocellular Carcinoma 2020, 7:45-76
Published Date: 15 April 2020
Rare Site Hepatocellular Carcinoma Metastasis
Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N
Journal of Hepatocellular Carcinoma 2020, 7:39-44
Published Date: 25 March 2020

Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really?
Dominguez DA, Wang XW
Journal of Hepatocellular Carcinoma 2020, 7:33-37
Published Date: 19 March 2020
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:19-31
Published Date: 18 February 2020
The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
Singh P, Toom S, Avula A, Kumar V, Rahma OE
Journal of Hepatocellular Carcinoma 2020, 7:11-17
Published Date: 10 February 2020
Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction
Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD
Journal of Hepatocellular Carcinoma 2020, 7:1-9
Published Date: 7 January 2020


Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves


El Kassas M, Tawheed A, Eltabbakh M, Kaseb A
Journal of Hepatocellular Carcinoma 2019, 6:183-191
Published Date: 19 November 2019
Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida
Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E
Journal of Hepatocellular Carcinoma 2019, 6:167-181
Published Date: 15 November 2019

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S
Journal of Hepatocellular Carcinoma 2019, 6:151-166
Published Date: 18 October 2019

Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study
Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K
Journal of Hepatocellular Carcinoma 2019, 6:143-150
Published Date: 8 October 2019
Status of, and strategies for improving, adherence to HCC screening and surveillance
Francica G, Borzio M
Journal of Hepatocellular Carcinoma 2019, 6:131-141
Published Date: 24 July 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M
Journal of Hepatocellular Carcinoma 2019, 6:119-129
Published Date: 22 July 2019
Intermediate stage hepatocellular carcinoma: a summary review
Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I
Journal of Hepatocellular Carcinoma 2019, 6:105-117
Published Date: 11 July 2019
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK
Journal of Hepatocellular Carcinoma 2019, 6:93-103
Published Date: 17 June 2019


Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma


Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML
Journal of Hepatocellular Carcinoma 2019, 6:85-91
Published Date: 6 June 2019

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Lu LC, Chang CJ, Hsu CH
Journal of Hepatocellular Carcinoma 2019, 6:71-84
Published Date: 7 May 2019

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB
Journal of Hepatocellular Carcinoma 2019, 6:49-69
Published Date: 5 February 2019

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK
Journal of Hepatocellular Carcinoma 2019, 6:41-48
Published Date: 31 January 2019

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Personeni N, Pressiani T, Rimassa L
Journal of Hepatocellular Carcinoma 2019, 6:31-39
Published Date: 31 January 2019
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Geh D, Rana FA, Reeves HL
Journal of Hepatocellular Carcinoma 2019, 6:23-30
Published Date: 14 January 2019


Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Stavraka C, Rush H, Ross P
Journal of Hepatocellular Carcinoma 2019, 6:11-21
Published Date: 28 December 2018
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M
Journal of Hepatocellular Carcinoma 2019, 6:1-10
Published Date: 21 December 2018
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I
Journal of Hepatocellular Carcinoma 2018, 5:109-119
Published Date: 19 November 2018


Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
Quaglia A
Journal of Hepatocellular Carcinoma 2018, 5:99-108
Published Date: 8 November 2018
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
Gilabert M, Raoul JL
Journal of Hepatocellular Carcinoma 2018, 5:91-98
Published Date: 2 November 2018
Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
de Jesus VHF, Dettino ALA
Journal of Hepatocellular Carcinoma 2018, 5:87-90
Published Date: 3 October 2018


Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer


Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA
Journal of Hepatocellular Carcinoma 2018, 5:81-86
Published Date: 2 August 2018

Hepatocellular cancer pain: impact and management challenges
Christian-Miller N, Frenette C
Journal of Hepatocellular Carcinoma 2018, 5:75-80
Published Date: 19 July 2018

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM
Journal of Hepatocellular Carcinoma 2018, 5:61-73
Published Date: 27 June 2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Griffith AS, Hayashi PH, Burke LMB, McRee AJ
Journal of Hepatocellular Carcinoma 2018, 5:55-59
Published Date: 31 May 2018
Editorial: charting the future of hepatocellular carcinoma publications
Kaseb AO
Journal of Hepatocellular Carcinoma 2018, 5:51-54
Published Date: 8 May 2018

Basic MRI for the liver oncologists and surgeons
Vu LN, Morelli JN, Szklaruk J
Journal of Hepatocellular Carcinoma 2018, 5:37-50
Published Date: 10 April 2018
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M
Journal of Hepatocellular Carcinoma 2018, 5:29-36
Published Date: 27 February 2018
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
Najjar M, Agrawal S, Emond JC, Halazun KJ
Journal of Hepatocellular Carcinoma 2018, 5:17-28
Published Date: 18 January 2018
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N
Journal of Hepatocellular Carcinoma 2018, 5:9-15
Published Date: 12 January 2018

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ
Journal of Hepatocellular Carcinoma 2018, 5:1-7
Published Date: 12 January 2018
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G
Journal of Hepatocellular Carcinoma 2017, 4:139-151
Published Date: 28 November 2017

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Ray EM, Sanoff HK
Journal of Hepatocellular Carcinoma 2017, 4:131-138
Published Date: 8 November 2017

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP
Journal of Hepatocellular Carcinoma 2017, 4:123-130
Published Date: 16 October 2017

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM
Journal of Hepatocellular Carcinoma 2017, 4:111-121
Published Date: 7 August 2017

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L
Journal of Hepatocellular Carcinoma 2017, 4:105-110
Published Date: 27 July 2017

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M
Journal of Hepatocellular Carcinoma 2017, 4:93-103
Published Date: 11 July 2017

Hepatocellular carcinoma: early-stage management challenges
Erstad DJ, Tanabe KK
Journal of Hepatocellular Carcinoma 2017, 4:81-92
Published Date: 23 June 2017

Screening for hepatocellular carcinoma: patient selection and perspectives
Fateen W, Ryder SD
Journal of Hepatocellular Carcinoma 2017, 4:71-79
Published Date: 17 May 2017

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L
Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS
Journal of Hepatocellular Carcinoma 2017, 4:59-69
Published Date: 12 April 2017

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
Zimmerman A, Grand D, Charpentier KP
Journal of Hepatocellular Carcinoma 2017, 4:49-58
Published Date: 13 March 2017
A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus
Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S
Journal of Hepatocellular Carcinoma 2017, 4:41-47
Published Date: 7 March 2017


Liver Imaging Reporting and Data System: an expert consensus statement
Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB
Journal of Hepatocellular Carcinoma 2017, 4:29-39
Published Date: 17 February 2017

Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge
Francica G
Journal of Hepatocellular Carcinoma 2017, 4:23-27
Published Date: 20 January 2017

Pediatric hepatocellular carcinoma: challenges and solutions
Schmid I, von Schweinitz D
Journal of Hepatocellular Carcinoma 2017, 4:15-21
Published Date: 16 January 2017
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Zhong J, Luo C, Zhang C, Li L
Journal of Hepatocellular Carcinoma 2017, 4:11-13
Published Date: 30 December 2016

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration
Ma KW, Cheung TT
Journal of Hepatocellular Carcinoma 2017, 4:1-9
Published Date: 28 December 2016

Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
Pievsky D, Pyrsopoulos N
Journal of Hepatocellular Carcinoma 2016, 3:69-76
Published Date: 15 November 2016

GPC-3 in hepatocellular carcinoma: current perspectives
Wu Y, Liu H, Ding H
Journal of Hepatocellular Carcinoma 2016, 3:63-67
Published Date: 8 November 2016
Minimally invasive image-guided therapies for hepatocellular carcinoma
Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC
Journal of Hepatocellular Carcinoma 2016, 3:55-61
Published Date: 11 October 2016

Hepatocellular carcinoma: a review
Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP
Journal of Hepatocellular Carcinoma 2016, 3:41-53
Published Date: 5 October 2016
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary
Mizejewski GJ
Journal of Hepatocellular Carcinoma 2016, 3:37-40
Published Date: 21 September 2016

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Trojan J, Waidmann O
Journal of Hepatocellular Carcinoma 2016, 3:31-36
Published Date: 21 September 2016

Transarterial radioembolization for hepatocellular carcinoma: a review
Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L
Journal of Hepatocellular Carcinoma 2016, 3:25-29
Published Date: 25 July 2016

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients
Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:19-24
Published Date: 14 June 2016

Hepatocellular carcinoma in elderly patients: challenges and solutions
Brunot A, Le Sourd S, Pracht M, Edeline J
Journal of Hepatocellular Carcinoma 2016, 3:9-18
Published Date: 17 June 2016

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:1-7
Published Date: 5 February 2016

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
Lafaro KJ, Pawlik TM
Journal of Hepatocellular Carcinoma 2015, 2:151-157
Published Date: 9 October 2015


Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma


Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS
Journal of Hepatocellular Carcinoma 2015, 2:143-149
Published Date: 6 October 2015

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:131-142
Published Date: 18 September 2015

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
Jang JH, Lee JW, Hong JT, Jin YJ
Journal of Hepatocellular Carcinoma 2015, 2:123-129
Published Date: 2 September 2015

Whither α-FP in the diagnosis of hepatocellular carcinoma?
Kew MC
Journal of Hepatocellular Carcinoma 2015, 2:119-121
Published Date: 24 August 2015

State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization

Luersen GF, Bhosale P, Szklaruk J
Journal of Hepatocellular Carcinoma 2015, 2:101-117
Published Date: 10 July 2015

The androgen receptor as an emerging target in hepatocellular carcinoma
Kanda T, Yokosuka O
Journal of Hepatocellular Carcinoma 2015, 2:91-99
Published Date: 26 June 2015


Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Journal of Hepatocellular Carcinoma 2015, 2:79-89
Published Date: 22 June 2015

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma
Valero V III, Pawlik TM, Anders RA
Journal of Hepatocellular Carcinoma 2015, 2:69-78
Published Date: 18 June 2015

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF
Journal of Hepatocellular Carcinoma 2015, 2:57-68
Published Date: 9 June 2015

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields
Beebe SJ
Journal of Hepatocellular Carcinoma 2015, 2:49-55
Published Date: 22 May 2015

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH
Journal of Hepatocellular Carcinoma 2015, 2:39-47
Published Date: 28 April 2015

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
Granito A, Guidetti E, Gramantieri L
Journal of Hepatocellular Carcinoma 2015, 2:29-38
Published Date: 24 April 2015

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
Cauchy F, Belghiti J
Journal of Hepatocellular Carcinoma 2015, 2:19-27
Published Date: 23 February 2015

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
Yang J, Li M, Zheng QC
Journal of Hepatocellular Carcinoma 2015, 2:11-17
Published Date: 16 February 2015

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors
Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M
Journal of Hepatocellular Carcinoma 2015, 2:3-9
Published Date: 30 January 2015

Welcome to Journal of Hepatocellular Carcinoma
Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:1-2
Published Date: 9 January 2015

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E
Journal of Hepatocellular Carcinoma 2014, 1:187-193
Published Date: 27 November 2014

Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Aiolfi R, Sitia G
Journal of Hepatocellular Carcinoma 2014, 1:183-186
Published Date: 13 November 2014

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
Cappelli A, Pettinato C, Golfieri R
Journal of Hepatocellular Carcinoma 2014, 1:163-182
Published Date: 3 November 2014

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
Braidwood L, Learmonth K, Graham A, Conner J
Journal of Hepatocellular Carcinoma 2014, 1:149-161
Published Date: 16 October 2014

Radiological diagnosis of hepatocellular carcinoma
Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C
Journal of Hepatocellular Carcinoma 2014, 1:137-148
Published Date: 9 September 2014


Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma


Hsu HT, Chi CW
Journal of Hepatocellular Carcinoma 2014, 1:127-135
Published Date: 26 August 2014

Hepatocellular carcinoma: epidemiology and risk factors
Kew MC
Journal of Hepatocellular Carcinoma 2014, 1:115-125
Published Date: 13 August 2014

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
Torres HA, Kaseb A, Mahale P, Miller E, Frenette C
Journal of Hepatocellular Carcinoma 2014, 1:109-114
Published Date: 16 July 2014

Clinical utility of imaging for evaluation of hepatocellular carcinoma
Murakami T, Tsurusaki M, Hyodo T, Imai Y
Journal of Hepatocellular Carcinoma 2014, 1:101-108
Published Date: 14 July 2014

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL
Journal of Hepatocellular Carcinoma 2014, 1:85-99
Published Date: 12 June 2014


New insights on the role of epigenetic alterations in hepatocellular carcinoma


Frau M, Feo CF, Feo F, Pascale RM
Journal of Hepatocellular Carcinoma 2014, 1:65-83
Published Date: 12 June 2014

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA
Journal of Hepatocellular Carcinoma 2014, 1:55-63
Published Date: 9 June 2014

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
Coleman SJ, Grose RP, Kocher HM
Journal of Hepatocellular Carcinoma 2014, 1:43-54
Published Date: 29 May 2014

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
Ofuji K, Saito K, Yoshikawa T, Nakatsura T
Journal of Hepatocellular Carcinoma 2014, 1:35-42
Published Date: 21 May 2014

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
Li L, Diao W, Zen K
Journal of Hepatocellular Carcinoma 2014, 1:21-33
Published Date: 21 May 2014

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D
Journal of Hepatocellular Carcinoma 2014, 1:9-19
Published Date: 26 March 2014

A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors
Shi J, Keller JM, Zhang J, Keller ET
Journal of Hepatocellular Carcinoma 2014, 1:1-7
Published Date: 6 March 2014